Skip to content
TrialScanner

NCT01241500

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Phase 3CompletedTRAWLead

Registry record

Lead sponsor
Traws Pharma, Inc.
Conditions
Myelodysplastic Syndromes; MDS; RAEB; Chronic Myelomonocytic Leukemia
Primary completion
Oct 3, 2018Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01241500 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01241500: Randomized Study of ON... | TrialScanner